Quantitative MRI of liver grafts for assessment of macrovesicular steatosis ex vivo and long-term follow-up outcomes
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dutkowski P, Linecker M, DeOliveira ML, Mullhaupt B, Clavien PA. Challenges to liver transplantation and strategies to improve outcomes. Gastroenterology. 2015;148:307–23. https://doi.org/10.1053/j.gastro.2014.08.045.
Boteon YL, Boteon A, Attard J, Mergental H, Mirza DF, Bhogal RH, et al. Ex situ machine perfusion as a tool to recondition steatotic donor livers: troublesome features of fatty livers and the role of defatting therapies. A System Rev Am J Transp. 2018;18:2384–99. https://doi.org/10.1111/ajt.14992.
Halliday N, Westbrook RH. Liver transplantation: post-transplant management. Br J Hosp Med (Lond). 2017. https://doi.org/10.12968/hmed.2017.78.5.278.
Garcia-Valdecasas Salgado JC. Non beating heart donors as a possible source for liver transplantation. Acta Chir Belg. 2000;100:268–71.
Winter A, Feray C, Audureau E, Ecochard R, Jacquelinet C, Roudot-Thoraval F, et al. External validation of the donor risk index and the Eurotransplant donor risk index on the French liver transplantation registry. Liver Int. 2017;37:1229–38. https://doi.org/10.1111/liv.13378.
Jimenez-Romero C, Caso Maestro O, Cambra Molero F, Justo Alonso I, Alegre Torrado C, Manrique Municio A, et al. Using old liver grafts for liver transplantation: where are the limits? World J Gastroenterol. 2014;20:10691–702. https://doi.org/10.3748/wjg.v20.i31.10691.
Busquets J, Xiol X, Figueras J, Jaurrieta E, Torras J, Ramos E, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation. 2001;71:1765–71. https://doi.org/10.1097/00007890-200106270-00011.
Croome KP, Lee DD, Taner CB. The “Skinny” on assessment and utilization of steatotic liver grafts: a systematic review. Liver Transpl. 2019;25:488–99. https://doi.org/10.1002/lt.25408.
Jackson KR, Motter JD, Haugen CE, Holscher C, Long JJ, Massie AB, et al. Temporal trends in utilization and outcomes of steatotic donor livers in the United States. Am J Transplant. 2020;20:855–63. https://doi.org/10.1111/ajt.15652.
Flechtenmacher C, Schirmacher P, Schemmer P. Donor liver histology–a valuable tool in graft selection. Langenbecks Arch Surg. 2015;400:551–7. https://doi.org/10.1007/s00423-015-1298-7.
Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010;16:874–84. https://doi.org/10.1002/lt.22085.
Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, et al. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl. 2009;15:1821–5. https://doi.org/10.1002/lt.21948.
Briceno J, Ciria R, Pleguezuelo M, de la Mata M, Muntane J, Naranjo A, et al. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl. 2009;15:37–48. https://doi.org/10.1002/lt.21566.
Angele MK, Rentsch M, Hartl WH, Wittmann B, Graeb C, Jauch KW, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg. 2008;195:214–20. https://doi.org/10.1016/j.amjsurg.2007.02.023.
Petrick A, Benotti P, Wood GC, Still CD, Strodel WE, Gabrielsen J, et al. Utility of ultrasound, transaminases, and visual inspection to assess nonalcoholic fatty liver disease in bariatric surgery patients. Obes Surg. 2015;25:2368–75. https://doi.org/10.1007/s11695-015-1707-6.
Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500. https://doi.org/10.1056/nejm200102153440706.
El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg. 2009;250:691–7. https://doi.org/10.1097/SLA.0b013e3181bcd6dd.
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898–906. https://doi.org/10.1053/j.gastro.2005.03.084.
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21. https://doi.org/10.1002/hep.20701.
Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–57. https://doi.org/10.1016/j.hep.2003.09.022.
Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 15 T. Radiology. 2009;251:67–76. https://doi.org/10.1148/radiol.2511080666.
Hines CD, Frydrychowicz A, Hamilton G, Tudorascu DL, Vigen KK, Yu H, et al. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging. 2011;33:873–81. https://doi.org/10.1002/jmri.22514.
Kuhn JP, Hernando D, Mensel B, Kruger PC, Ittermann T, Mayerle J, et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging. 2014;39:1494–501. https://doi.org/10.1002/jmri.24289.
Zhong X, Nickel MD, Kannengiesser SA, Dale BM, Kiefer B, Bashir MR. Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med. 2014;72:1353–65. https://doi.org/10.1002/mrm.25054.
Chen G, Jiang J, Wang X, Yang M, Xie Y, Guo H, et al. Evaluation of hepatic steatosis before liver transplantation in ex vivo by volumetric quantitative PDFF-MRI. Magn Reson Med. 2021;85:2805–14. https://doi.org/10.1002/mrm.28592.
Satapathy SK, Gonzalez HC, Vanatta J, Dyer A, Angel W, Nouer SS, et al. A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction. PLoS ONE. 2020;15: e0232006. https://doi.org/10.1371/journal.pone.0232006.
Bannas P, Kramer H, Hernando D, Agni R, Cunningham AM, Mandal R, et al. Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology. 2015;62:1444–55. https://doi.org/10.1002/hep.28012.
Young LAJ, Ceresa CDL, Mozes FE, Ellis J, Valkovic L, Colling R, et al. Noninvasive assessment of steatosis and viability of cold-stored human liver grafts by MRI. Magn Reson Med. 2021;86:3246–58. https://doi.org/10.1002/mrm.28930.
Agopian VG, Harlander-Locke MP, Markovic D, Dumronggittigule W, Xia V, Kaldas FM, et al. Evaluation of early allograft function using the liver graft assessment following transplantation risk score model. JAMA Surg. 2018;153:436–44. https://doi.org/10.1001/jamasurg.2017.5040.
Bonekamp S, Tang A, Mashhood A, Wolfson T, Changchien C, Middleton MS, et al. Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging. 2014;39:1525–32. https://doi.org/10.1002/jmri.24321.
Vu KN, Gilbert G, Chalut M, Chagnon M, Chartrand G, Tang A. MRI-determined liver proton density fat fraction, with MRS validation: comparison of regions of interest sampling methods in patients with type 2 diabetes. J Magn Reson Imaging. 2016;43:1090–9. https://doi.org/10.1002/jmri.25083.
Hong CW, Wolfson T, Sy EZ, Schlein AN, Hooker JC, Fazeli Dehkordy S, et al. Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification. J Magn Reson Imaging. 2018;47:988–94. https://doi.org/10.1002/jmri.25843.
Wildman-Tobriner B, Middleton MM, Moylan CA, Rossi S, Flores O, Chang ZA, et al. Association between magnetic resonance imaging-proton density fat fraction and liver histology features in patients with nonalcoholic fatty liver disease or Nonalcoholic Steatohepatitis. Gastroenterology. 2018;155(1428–1435): e1422. https://doi.org/10.1053/j.gastro.2018.07.018.
Kuhn JP, Hernando D, Munoz del Rio A, Evert M, Kannengiesser S, Volzke H, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology. 2012;265:133–42. https://doi.org/10.1148/radiol.12112520.
Gu J, Liu S, Du S, Zhang Q, Xiao J, Dong Q, et al. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol. 2019;29:3564–73. https://doi.org/10.1007/s00330-019-06072-4.